851607-30-2

Basic information

• Product Name: 3-BroMo-5-chloro-2-Methoxy-4-Methylpyridine
• Synonyms: 3-BroMo-5-chloro-2-Methoxy-4-Methylpyridine
• CAS NO: 851607-30-2
• Molecular Formula: C₇H₇BrClNO
• Molecular Weight: 236.49358
• Mol File: 851607-30-2.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-BroMo-5-chloro-2-Methoxy-4-Methylpyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BroMo-5-chloro-2-Methoxy-4-Methylpyridine(851607-30-2)
• EPA Substance Registry System: 3-BroMo-5-chloro-2-Methoxy-4-Methylpyridine(851607-30-2)

Safety Data

• Hazardous Substances Data: 851607-30-2(Hazardous Substances Data)

Usage

InChI:InChI=1S/C7H7BrClNO/c1-4-5(9)3-10-7(11-2)6(4)8/h3H,1-2H3

Upstream product

• 851607-29-9 5-chloro-2-methoxy-4-methylpyridine 
• 133627-45-9 3-Amino-2-chloro-4-methylpyridine 
• 55404-31-4 3-bromo-2-chloro-4-methylpyridine 
• 717843-51-1 3-bromo-2-methoxy-4-methyl-pyridine 

Downstream Products

• 688046-61-9 3-(2,3,4-trimethoxy-6-methylbenzoyl)-5-chloro-2-methoxy-4-methylpyridine 
• 851607-38-0 5-chloro-2-methoxy-4-methyl nicotinic acid 

Relevant articles and documents

PYRAZOLOQUINOLINE DERIVATIVES

A compound and/or pharmacologically acceptable salt thereof represented by the formula (I) has PDE9 inhibitory action, so that the intracerebral cGMP concentration is anticipated to be elevated. The PDE9 inhibitory action and the increase in cGMP lead to the improvement of learning and memory behaviors, and the compound (I) has applicability as a therapeutic agent for cognitive dysfunctions in Alzheimer's disease. wherein R1 is a hydrogen atom; R2 is an aromatic ring group, etc.; R3 is a hydrogen atom, etc; R4 is a hydrogen atom; R5 is an oxepanyl group, etc.; R6 is a hydrogen atom.